Gyógyszeres kezelés okozta csontelhalás az állcsontokban

Translated title of the contribution: Medicine-induced osteonecrosis of the jaw

Vaszilkó Mihály, Cséplo Krisztina, Z. Németh, J. Barabás, M. Ujpál

Research output: Contribution to journalArticle

Abstract

INTRODUCTION - Bisphosphonates are often used in the treatment of osteoporosis and of certain tumors with bone defects. Thus their rare side effect, necrosis of the jaw becomes more and more frequent. CASE REPORT - Between September 2005 and March 2008 we have treated 40 patients with bisphosphonate induced osteonecrosis in the maxillofacial region at our hospital. From this group, we selected two cases where typical complications emerged. CONCLUSION - Based upon data from the international literature and on our own experiences, we would like to draw attention to the importance of prevention. If symptoms are emerging, referral to a specialized department prepared to the treatment of this condition is recommended.

Original languageHungarian
Pages (from-to)47-49
Number of pages3
JournalLege Artis Medicinae
Volume19
Issue number1
Publication statusPublished - Jan 2009

Fingerprint

Osteonecrosis
Jaw
Bisphosphonate-Associated Osteonecrosis of the Jaw
Medicine
Diphosphonates
Osteoporosis
Necrosis
Referral and Consultation
Bone and Bones
Therapeutics
Neoplasms

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Gyógyszeres kezelés okozta csontelhalás az állcsontokban. / Mihály, Vaszilkó; Krisztina, Cséplo; Németh, Z.; Barabás, J.; Ujpál, M.

In: Lege Artis Medicinae, Vol. 19, No. 1, 01.2009, p. 47-49.

Research output: Contribution to journalArticle

Mihály, Vaszilkó ; Krisztina, Cséplo ; Németh, Z. ; Barabás, J. ; Ujpál, M. / Gyógyszeres kezelés okozta csontelhalás az állcsontokban. In: Lege Artis Medicinae. 2009 ; Vol. 19, No. 1. pp. 47-49.
@article{19e5a9ad682a4391ae5e35e709f48aa4,
title = "Gy{\'o}gyszeres kezel{\'e}s okozta csontelhal{\'a}s az {\'a}llcsontokban",
abstract = "INTRODUCTION - Bisphosphonates are often used in the treatment of osteoporosis and of certain tumors with bone defects. Thus their rare side effect, necrosis of the jaw becomes more and more frequent. CASE REPORT - Between September 2005 and March 2008 we have treated 40 patients with bisphosphonate induced osteonecrosis in the maxillofacial region at our hospital. From this group, we selected two cases where typical complications emerged. CONCLUSION - Based upon data from the international literature and on our own experiences, we would like to draw attention to the importance of prevention. If symptoms are emerging, referral to a specialized department prepared to the treatment of this condition is recommended.",
keywords = "Bisphosphonates, Jaw, Osteonecrosis",
author = "Vaszilk{\'o} Mih{\'a}ly and Cs{\'e}plo Krisztina and Z. N{\'e}meth and J. Barab{\'a}s and M. Ujp{\'a}l",
year = "2009",
month = "1",
language = "Hungarian",
volume = "19",
pages = "47--49",
journal = "Lege Artis Medicinae",
issn = "0866-4811",
publisher = "Literatura Medica Publishing House",
number = "1",

}

TY - JOUR

T1 - Gyógyszeres kezelés okozta csontelhalás az állcsontokban

AU - Mihály, Vaszilkó

AU - Krisztina, Cséplo

AU - Németh, Z.

AU - Barabás, J.

AU - Ujpál, M.

PY - 2009/1

Y1 - 2009/1

N2 - INTRODUCTION - Bisphosphonates are often used in the treatment of osteoporosis and of certain tumors with bone defects. Thus their rare side effect, necrosis of the jaw becomes more and more frequent. CASE REPORT - Between September 2005 and March 2008 we have treated 40 patients with bisphosphonate induced osteonecrosis in the maxillofacial region at our hospital. From this group, we selected two cases where typical complications emerged. CONCLUSION - Based upon data from the international literature and on our own experiences, we would like to draw attention to the importance of prevention. If symptoms are emerging, referral to a specialized department prepared to the treatment of this condition is recommended.

AB - INTRODUCTION - Bisphosphonates are often used in the treatment of osteoporosis and of certain tumors with bone defects. Thus their rare side effect, necrosis of the jaw becomes more and more frequent. CASE REPORT - Between September 2005 and March 2008 we have treated 40 patients with bisphosphonate induced osteonecrosis in the maxillofacial region at our hospital. From this group, we selected two cases where typical complications emerged. CONCLUSION - Based upon data from the international literature and on our own experiences, we would like to draw attention to the importance of prevention. If symptoms are emerging, referral to a specialized department prepared to the treatment of this condition is recommended.

KW - Bisphosphonates

KW - Jaw

KW - Osteonecrosis

UR - http://www.scopus.com/inward/record.url?scp=61849139999&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=61849139999&partnerID=8YFLogxK

M3 - Article

VL - 19

SP - 47

EP - 49

JO - Lege Artis Medicinae

JF - Lege Artis Medicinae

SN - 0866-4811

IS - 1

ER -